TKR-1785-I

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTKR-1785-I
Drug Alias NameTKR-1785-ITKR-1785-II
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCandida Albicans InfectionsCryptococcosisAspergillosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakara Shuzo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakara Shuzo
Active IndicationsN/A
Inactive IndicationsCandida Albicans InfectionsCryptococcosisAspergillosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A